Back to Search
Start Over
Obesity is associated with improved progression-free survival in MSI-H endometrial cancer treated with pembrolizumab (2260).
- Source :
-
Gynecologic Oncology . 2023 Supplement 1, Vol. 176, pS291-S291. 1p. - Publication Year :
- 2023
- Subjects :
- *ENDOMETRIAL cancer
*PROGRESSION-free survival
*OBESITY
*PEMBROLIZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 00908258
- Volume :
- 176
- Database :
- Academic Search Index
- Journal :
- Gynecologic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 172305350
- Full Text :
- https://doi.org/10.1016/j.ygyno.2023.06.378